Status:
UNKNOWN
Three Anticoagulation Strategies for Hemodialysis in Patients at Risk of Hemorrhage
Lead Sponsor:
Guangdong Provincial People's Hospital
Conditions:
Hemodialysis
Anticoagulation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of our study is to assess three anticoagulation strategies for intermittent hemodialysis(IHD) in patients at risk of hemorrhage. A registry of consecutive hemodialysis patients with high risk ...
Detailed Description
Briefly, there are two parts in this study. The first part of the study is to compare two-stage RCA with one stage RCA during IHD, and the second part is to compare two-stage RCA with regular saline f...
Eligibility Criteria
Inclusion
- age\>=18 years
- intermittent hemodialysis patients that carry on a 4 hours hemodialysis procedure, 2-3 times one week.
- the therapy mode is hemodialysis，with a dialysis fluid more than 500ml/min and blood flow volume more than 3.5-4ml/min.kg；
- at risk of hemorrhage,including active hemorrhage(within 3 days),post-operation(within 3 days) and pre-invasive operation(within 7 days).
Exclusion
- at high risk of citrate accumulation( total bilirubin \>60umol/L; lactic acid\>3mmol/L,）；
- use the drugs that impact the coagulation function within 7 days;
- serious hypocalcemia (serum calcium\<1.9mmol/L).
Key Trial Info
Start Date :
September 10 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 30 2019
Estimated Enrollment :
141 Patients enrolled
Trial Details
Trial ID
NCT03419923
Start Date
September 10 2017
End Date
March 30 2019
Last Update
December 12 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangdong General Hospital
Guangzhou, Guangdong, China, 510515